Invention Grant
US07875711B2 Compositions and methods for inhibiting expression of XBP-1 gene
有权
用于抑制XBP-1基因表达的组合物和方法
- Patent Title: Compositions and methods for inhibiting expression of XBP-1 gene
- Patent Title (中): 用于抑制XBP-1基因表达的组合物和方法
-
Application No.: US12425811Application Date: 2009-04-17
-
Publication No.: US07875711B2Publication Date: 2011-01-25
- Inventor: Kevin Fitzgerald , Gregory Hinkle
- Applicant: Kevin Fitzgerald , Gregory Hinkle
- Applicant Address: US MA Cambridge
- Assignee: Alnylam Pharamaceuticals, Inc.
- Current Assignee: Alnylam Pharamaceuticals, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Fenwick & West LLP
- Main IPC: C07H21/04
- IPC: C07H21/04
Abstract:
The invention relates to a double-stranded ribonucleic acid (dsRNA) targeting X-Box Protein 1 (XBP-1), and methods of using the dsRNA to inhibit expression of XBP-1.
Public/Granted literature
- US20090275638A1 Compositions and Methods for Inhibiting Expression of XBP-1 Gene Public/Granted day:2009-11-05
Information query
